Literature DB >> 16354588

Expression of axl in lung adenocarcinoma and correlation with tumor progression.

Yi-Shing Shieh1, Chiung-Ya Lai, Yu-Rung Kao, Shine-Gwo Shiah, Yi-Wen Chu, Herng-Sheng Lee, Cheng-Wen Wu.   

Abstract

We used the Transwell system to select highly invasive cell lines from minimally invasive parent cells, and we compared gene expression in paired cell lines with high and low invasive potentials. Axl was relatively overexpressed in the highly invasive cell lines when compared with their minimally invasive counterparts. However, there is only limited information about the role of Axl in cancer invasion. The biologic function of Axl in tumor invasion was investigated by overexpression of full-length Axl in minimally invasive cells and by siRNA knockdown of Axl expression in highly invasive cells. Overexpression of Axl in minimally invasive cells increased their invasiveness. siRNA reduced cell invasiveness as Axl was downregulated in highly invasive cells. We further investigated the protein expression of Axl by immunohistochemistry and its correlation with clinicopathologic features. Data from a study of 58 patient specimens showed that Axl immunoreactivity was statistically significant with respect to lymph node status (P < .0001) and the patient's clinical stage (P < .0001). Our results demonstrate that Axl protein kinase seems to play an important role in the invasion and progression of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16354588      PMCID: PMC1501169          DOI: 10.1593/neo.05640

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  27 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detection.

Authors:  J J Chen; R Wu; P C Yang; J Y Huang; Y P Sher; M H Han; W C Kao; P J Lee; T F Chiu; F Chang; Y W Chu; C W Wu; K Peck
Journal:  Genomics       Date:  1998-08-01       Impact factor: 5.736

3.  tie-1 protein tyrosine kinase: a novel independent prognostic marker for gastric cancer.

Authors:  W C Lin; A F Li; C W Chi; W W Chung; C L Huang; W Y Lui; H J Kung; C W Wu
Journal:  Clin Cancer Res       Date:  1999-07       Impact factor: 12.531

4.  Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.

Authors:  K O'Donnell; I C Harkes; L Dougherty; I P Wicks
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

5.  Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast.

Authors:  G Berclaz; H J Altermatt; V Rohrbach; I Kieffer; E Dreher; A C Andres
Journal:  Ann Oncol       Date:  2001-06       Impact factor: 32.976

6.  Comparative tyrosine-kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa.

Authors:  W S Chen; H J Kung; W K Yang; W c Lin
Journal:  Int J Cancer       Date:  1999-11-26       Impact factor: 7.396

7.  Expression of the Axl receptor tyrosine kinase in human thyroid carcinoma.

Authors:  T Ito; M Ito; S Naito; A Ohtsuru; Y Nagayama; T Kanematsu; S Yamashita; I Sekine
Journal:  Thyroid       Date:  1999-06       Impact factor: 6.568

8.  Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion.

Authors:  A Wimmel; D Glitz; A Kraus; J Roeder; M Schuermann
Journal:  Eur J Cancer       Date:  2001-11       Impact factor: 9.162

9.  Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK).

Authors:  C Rochlitz; A Lohri; M Bacchi; M Schmidt; S Nagel; M Fopp; M F Fey; R Herrmann; A Neubauer
Journal:  Leukemia       Date:  1999-09       Impact factor: 11.528

10.  Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras.

Authors:  S Goruppi; E Ruaro; B Varnum; C Schneider
Journal:  Oncogene       Date:  1999-07-22       Impact factor: 9.867

View more
  117 in total

1.  Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma.

Authors:  Xianzhou Song; Hua Wang; Craig D Logsdon; Asif Rashid; Jason B Fleming; James L Abbruzzese; Henry F Gomez; Douglas B Evans; Huamin Wang
Journal:  Cancer       Date:  2010-10-04       Impact factor: 6.860

2.  Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.

Authors:  Amy K Keating; Grace K Kim; Ashley E Jones; Andrew M Donson; Kathryn Ware; Jean M Mulcahy; Dana B Salzberg; Nicholas K Foreman; Xiayuan Liang; Andrew Thorburn; Douglas K Graham
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

Review 3.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

4.  Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway.

Authors:  Jingchao Xu; Li Jia; Hongye Ma; Yanping Li; Zhenhai Ma; Yongfu Zhao
Journal:  Tumour Biol       Date:  2013-12-18

Review 5.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

6.  AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.

Authors:  Anna de Polo; Zhongling Luo; Casimiro Gerarduzzi; Xiang Chen; John B Little; Zhi-Min Yuan
Journal:  J Mol Cell Biol       Date:  2017-04-01       Impact factor: 6.216

7.  Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma.

Authors:  Ren Liu; Ming Gong; Xiuqing Li; Yue Zhou; Wenming Gao; Anil Tulpule; Preet M Chaudhary; Jae Jung; Parkash S Gill
Journal:  Blood       Date:  2010-05-04       Impact factor: 22.113

8.  Axl receptor tyrosine kinase expression in breast cancer.

Authors:  Timothy M D'Alfonso; Jeffrey Hannah; Zhengming Chen; Yifang Liu; Pengbo Zhou; Sandra J Shin
Journal:  J Clin Pathol       Date:  2014-06-05       Impact factor: 3.411

9.  AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.

Authors:  Toni M Brand; Mari Iida; Andrew P Stein; Kelsey L Corrigan; Cara M Braverman; John P Coan; Hannah E Pearson; Harsh Bahrar; Tyler L Fowler; Bryan P Bednarz; Sandeep Saha; David Yang; Parkash S Gill; Mark W Lingen; Vassiliki Saloura; Victoria M Villaflor; Ravi Salgia; Randall J Kimple; Deric L Wheeler
Journal:  Clin Cancer Res       Date:  2015-03-12       Impact factor: 12.531

10.  Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.

Authors:  Anna Gustafsson; Anna-Karin Boström; Börje Ljungberg; Håkan Axelson; Björn Dahlbäck
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.